Cipla partners with Eli Lilly to market diabetes drug Basaglar in India
Moneycontrolcom
Drug firm Cipla today said it has partnered with Eli Lilly to market and distribute Lillys insulin glargine injection, Basaglar, in India.
Moneycontrolcom
Drug firm Cipla today said it has partnered with Eli Lilly to market and distribute Lillys insulin glargine injection, Basaglar, in India.